Characterization of the pVHL Interactome in Human Testis Using High-Throughput Library Screening.

VHL hypoxia testis ubiquitination von Hippel–Lindau syndrome yeast two hybrid (Y2H)

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
17 Feb 2022
Historique:
received: 10 12 2021
revised: 12 02 2022
accepted: 13 02 2022
entrez: 25 2 2022
pubmed: 26 2 2022
medline: 26 2 2022
Statut: epublish

Résumé

Functional impairment of the von Hippel-Lindau tumor suppressor (pVHL) is causative of a familiar increased risk of developing cancer. As an E3 substrate recognition particle, pVHL marks the hypoxia inducible factor 1α (HIF-1α) for degradation in normoxic conditions, thus acting as a key regulator of both acute and chronic cell adaptation to hypoxia. The male mice model carrying VHL gene conditional knockout presents significant abnormalities in testis development paired with defects in spermatogenesis and infertility, indicating that pVHL exerts testis-specific roles. Here we aimed to explore whether pVHL could have a similar role in humans by performing a testis-tissue library screening complemented with in-depth bioinformatics analysis. We identified 55 novel pVHL binding proteins directly involved in spermatogenesis, cell differentiation and reproductive metabolism. In addition, computational investigation of these new interactors identified multiple pVHL-specific binding motifs and demonstrated that somatic mutations described in human cancers reside in these binding regions. Collectively, these findings suggest that, in addition to its role in cancer formation, pVHL may also be pivotal in normal gonadal development in humans.

Identifiants

pubmed: 35205757
pii: cancers14041009
doi: 10.3390/cancers14041009
pmc: PMC8869832
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Italian Association for Cancer Research
ID : IG 2019 ID. 23825

Références

Dev Cell. 2007 Apr;12(4):503-14
pubmed: 17395546
Bioinformatics. 2009 Apr 15;25(8):1091-3
pubmed: 19237447
Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11661-6
pubmed: 9751722
J Cell Biol. 2006 Nov 20;175(4):547-54
pubmed: 17101696
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Nucleic Acids Res. 2021 Jan 8;49(D1):D325-D334
pubmed: 33290552
Nucleic Acids Res. 2012 Jan;40(Database issue):D841-6
pubmed: 22121220
Nucleic Acids Res. 2020 Jan 8;48(D1):D296-D306
pubmed: 31680160
Mol Cell. 1998 Jun;1(7):959-68
pubmed: 9651579
Br J Cancer. 2015 Jul 14;113(2):336-44
pubmed: 26035699
Nat Rev Mol Cell Biol. 2018 Nov;19(11):697-712
pubmed: 30065390
Nat Genet. 2015 Jun;47(6):569-76
pubmed: 25915600
Cancer Res. 2003 Sep 1;63(17):5320-8
pubmed: 14500363
J Endocrinol Invest. 2018 Jan;41(1):21-31
pubmed: 28589383
Carcinogenesis. 2020 Jul 10;41(6):828-840
pubmed: 31556451
Science. 1993 May 28;260(5112):1317-20
pubmed: 8493574
Diabetologia. 2017 Oct;60(10):1977-1986
pubmed: 28711973
Nucleic Acids Res. 2011 Oct;39(19):e128
pubmed: 21785140
Urology. 1997 Jun;49(6):926-31
pubmed: 9187702
Science. 2002 Jun 7;296(5574):1886-9
pubmed: 12004076
Clin Cancer Res. 2009 Dec 15;15(24):7582-7592
pubmed: 19996202
Cells. 2020 Apr 08;9(4):
pubmed: 32276433
Cell Cycle. 2006 Sep;5(18):2054-6
pubmed: 16969113
Hum Mutat. 2010 May;31(5):521-37
pubmed: 20151405
J Comput Biol. 1994 Spring;1(1):39-50
pubmed: 8790452
Trends Cancer. 2019 Apr;5(4):245-262
pubmed: 30961831
Int J Cancer. 1998 Sep 25;78(1):62-9
pubmed: 9724095
Methods Mol Biol. 2012;812:39-61
pubmed: 22218853
Sci Rep. 2020 Sep 28;10(1):15850
pubmed: 32985545
Science. 1999 Apr 23;284(5414):657-61
pubmed: 10213691
Open Biol. 2020 Jul;10(7):200109
pubmed: 32603638
Nucleic Acids Res. 2017 Jan 4;45(D1):D369-D379
pubmed: 27980099
Cell. 2001 Oct 5;107(1):43-54
pubmed: 11595184
Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515
pubmed: 30395287
Nat Rev Clin Oncol. 2010 May;7(5):277-88
pubmed: 20368728
Clin Nucl Med. 2016 Oct;41(10):781-2
pubmed: 27454594
Oncol Lett. 2019 Mar;17(3):3041-3047
pubmed: 30867732
Science. 2016 Aug 26;353(6302):929-32
pubmed: 27563096
Andrology. 2019 Sep;7(5):588-602
pubmed: 31131532
Nat Cell Biol. 2003 Jan;5(1):64-70
pubmed: 12510195
Bioinformatics. 2009 May 1;25(9):1189-91
pubmed: 19151095
Nucleic Acids Res. 2021 Jan 8;49(D1):D605-D612
pubmed: 33237311
Nucleic Acids Res. 2017 Jan 4;45(D1):D777-D783
pubmed: 27899578
Mol Biol Cell. 2008 Dec;19(12):5296-308
pubmed: 18799616
Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W350-5
pubmed: 16845024
Mol Cell Biochem. 2017 Mar;427(1-2):145-156
pubmed: 28025795
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Nat Cell Biol. 2008 Mar;10(3):361-9
pubmed: 18297059
Biochem Biophys Res Commun. 2002 Jun 14;294(3):700-9
pubmed: 12056827
Mol Cell Biol. 2010 May;30(9):2105-19
pubmed: 20176811
FASEB J. 2011 Feb;25(2):600-12
pubmed: 20959514
Br J Cancer. 2009 Oct 6;101(7):1175-82
pubmed: 19789534
BMC Bioinformatics. 2003 Jan 13;4:2
pubmed: 12525261
Am J Surg Pathol. 2014 May;38(5):713-8
pubmed: 24441657
Nature. 2002 Apr 11;416(6881):648-53
pubmed: 11923872
Nature. 1997 May 15;387(6630):296-9
pubmed: 9153395
Anim Reprod Sci. 2021 Jul 14;:106805
pubmed: 34275685
Sci Rep. 2015 Jul 27;5:12605
pubmed: 26211615
Sci Rep. 2016 Aug 11;6:31128
pubmed: 27511743
EMBO Rep. 2005 Apr;6(4):373-8
pubmed: 15776016
Jpn J Clin Oncol. 2006 Jun;36(6):337-43
pubmed: 16818478
Science. 1999 Apr 16;284(5413):455-61
pubmed: 10205047

Auteurs

Antonella Falconieri (A)

Department of Biomedical Sciences, University of Padova, 35121 Padova, Italy.

Giovanni Minervini (G)

Department of Biomedical Sciences, University of Padova, 35121 Padova, Italy.

Federica Quaglia (F)

Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies, National Research Council (CNR-IBIOM), 70126 Bari, Italy.

Geppo Sartori (G)

Department of Biomedical Sciences, University of Padova, 35121 Padova, Italy.

Silvio C E Tosatto (SCE)

Department of Biomedical Sciences, University of Padova, 35121 Padova, Italy.

Classifications MeSH